Disclosure: This is an affiliate site. We may earn compensation from partners. Full disclosure | Medical disclaimer
Aggressive annual-plan pricing with a buy-three-get-one structure
Also searched as: Join Fridays, joinfridays
$117/mo
Compounded
Cash-pay
August 30, 2026
Fridays prices its compounded GLP-1 programs on a steep commitment curve. U.S. News reports compounded semaglutide starting at $117 a month on an annual plan and $198 a month otherwise, with compounded GLP-1/GIP (tirzepatide) starting around $198 a month on an annual plan.
Fridays' own help centre shows the month-to-month reality: a one-month plan at $359 and a three-month plan at $896 ($299 a month) on one tier, with another tier at $249 for one month. The gap between the $117 annual rate and the $359 monthly rate is the largest in this comparison set.
Fridays also runs a "buy 3, get 1 free" structure, applied as a 25% discount on a four-month membership. It offers both injectable and oral formulations and markets a microdosing approach.
Fridays dispenses compounded GLP-1 medications and states explicitly that it does not manufacture them. Compounded drugs are not FDA-approved and the FDA does not evaluate them for safety, effectiveness or quality.
Online intake and clinical review, included in the membership price.
Adults meeting standard GLP-1 criteria as assessed by the reviewing clinician.
Licensed clinicians handle prescribing and dose management as part of the membership.
Not publicly listed as a standard bundled requirement.
Compounding pharmacies. Fridays states it does not manufacture the medication itself. Specific pharmacy partners are not publicly named.
Included in the membership. Injectables require refrigerated cold-chain handling; oral formulations do not.
Membership includes clinician access. Fridays maintains a public help centre with pricing documentation, which is more transparent than most competitors.
Presented as an all-in membership rather than a separate platform fee. The membership price varies enormously by commitment length.
Included in the membership price.
Multi-month and annual plans are prepaid, which limits mid-term flexibility. Review the terms for your specific plan before purchase.
No published blanket refund policy. Prepaid annual plans carry significant financial exposure.
Not accepted. Fridays states compounded GLP-1 medications are not covered by insurance.
Reimbursement for compounded medication is uncertain. Confirm with your plan administrator before assuming eligibility.
Pricing in this review reflects what Fridays and named third-party sources published as of August 30, 2026. Telehealth pricing changes frequently — confirm the current figure at checkout before you buy.
People confident they will stay on a compounded program for a full year and who want the lowest possible annual rate. The oral formulation and microdosing options add flexibility.
The pricing structure is the main problem. A $117 headline that requires annual prepayment while the actual month-to-month rate is $359 makes honest comparison difficult, and public complaints reflect that. Prepaying a year in a category where the FDA has ended shortage-based compounding allowances is a real risk.
U.S. News reports compounded semaglutide starting at $117 a month on an annual plan and $198 a month otherwise. Fridays' own help centre lists a one-month plan at $359 and a three-month plan at $896 ($299 a month) on one tier, with another tier starting at $249 for one month. The commitment length drives the price enormously.
Fridays applies it as a 25% discount on the total four-month membership fee, equal in value to one month of the standard monthly membership. It is a genuine discount, not a free extra month layered on top.
No. Fridays dispenses compounded GLP-1 medications and states explicitly that it does not manufacture them. Compounded drugs are not FDA-approved and the FDA does not evaluate them for safety, effectiveness or quality.
Yes. Fridays lists both oral and injectable compounded semaglutide, and also markets microdosing protocols for people who want lower doses.
Because the price depends heavily on commitment length and product tier. The same program can be quoted at $117 a month on an annual plan or $359 for a single month. Reddit users have publicly raised this gap as a complaint. Check the actual checkout total for the specific plan you want.
No. Fridays states that compounded GLP-1 medications are not covered by insurance, which is why it prices for cash-pay patients.
Every pricing and policy claim on this page traces back to one of these sources, checked on August 30, 2026.
Lowest published rate, per U.S. News
Published starting rate outside the annual plan
Tirzepatide-containing product on an annual plan
Month-to-month pricing per the Fridays help centre, varies by tier
Billed in full upfront
Applied as a discount on the total four-month membership fee
Verified August 30, 2026. Prices change often — confirm before purchase.
Share your experience with Fridays to help others make informed decisions.
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with serious potential side effects and are not appropriate for everyone. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Compounded medications are not FDA-approved. The FDA does not evaluate compounded products for safety, effectiveness, or quality. Individual results vary. This page contains affiliate links, and we may earn compensation if you use them.
Date reviewed: August 30, 2026